Topics

Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS

19:00 EST 5 Nov 2019 | Arthritis Research and Therapy

A decade has passed since the publication on the comparison of the effect of adalimumab with data from a historic cohort on the progression of structural damage in the spine of patients with ankylosing spondyl...

Original Article: Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS

NEXT ARTICLE

More From BioPortfolio on "Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS"

Quick Search